Concourse Financial Group Securities, Inc. Aldeyra Therapeutics, Inc. Transaction History

Concourse Financial Group Securities, Inc.

$1.67 Billion
Q4 2024

Number of Shares

Previous 0 NaN%

Holding current value

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share
Q4 2024 Feb 13, 2025	BUY	$4.21 - $5.9 $0 - $0
Q3 2024 Oct 10, 2024	BUY	$3.19 - $6.32 $0 - $0
Q2 2024 Jul 23, 2024	BUY	$3.25 - $4.72 $0 - $0
Q1 2024 Apr 30, 2024	BUY	$2.77 - $4.22 $0 - $0
Q4 2023 Feb 07, 2024	BUY	$1.47 - $6.06 $0 - $0
Q3 2023 Oct 30, 2023	BUY	$6.11 - $8.16 $0 - $0
Q3 2023 Oct 25, 2023	BUY	$6.11 - $8.16 $0 - $0
Q2 2023 Aug 10, 2023	BUY	$7.11 - $11.89 $0 - $0
Q1 2023 May 15, 2023	BUY	$5.77 - $9.93 $0 - $0
Q4 2022 Jan 30, 2023	BUY	$5.08 - $7.09 $0 - $0
Q3 2022 Nov 15, 2022	BUY	$3.8 - $7.74 $0 - $0
Q2 2022 Aug 09, 2022	BUY	$2.43 - $4.85 $0 - $0
Q1 2022 May 09, 2022	BUY	$3.25 - $5.17 $0 - $0
Q4 2021 Feb 07, 2022	BUY	$3.5 - $9.63 $0 - $0
Q3 2021 Nov 09, 2021	BUY	$7.94 - $11.31 $0 - $0
Q2 2021 Aug 13, 2021	BUY	$10.44 - $14.85 $0 - $0
Q1 2021 May 13, 2021	BUY	$6.53 - $14.42 $0 - $0
Q4 2020 Feb 02, 2021	BUY	$6.31 - $8.13 $0 - $0
Q3 2020 Nov 13, 2020	BUY	$4.0 - $7.53 $0 - $0
Q2 2020 Aug 13, 2020	BUY	$1.97 - $5.05 $0 - $0
Q1 2020 May 13, 2020	BUY	$1.62 - $6.4 $0 - $0
Q4 2019 Feb 14, 2020	BUY	$4.73 - $7.98 $0 - $0
Q3 2019 Nov 13, 2019	BUY	$4.41 - $6.12 $0 - $0
Q2 2019 Aug 13, 2019	BUY	$6.0 - $9.0 $0 - $0
Q1 2019 May 15, 2019	BUY	$7.14 - $9.85 $0 - $0
Q4 2018 Feb 14, 2019	BUY	$7.26 - $13.29 $0 - $0
Q3 2018 Nov 13, 2018	BUY	$6.8 - $14.35 $0 - $0

Others Institutions Holding ALDX

# of Institutions

122

Shares Held

36.3M

Call Options Held

196K

Put Options Held

142K

Perceptive Advisors LLC New York, NY

9.28M
Shares

$60 Million
1.31% of portfolio
Knoll Capital Management, LLC Miami, FL

5.48M
Shares

$35.4 Million
14.56% of portfolio
Vanguard Group Inc Valley Forge, PA

3.76M
Shares

$24.3 Million
0.0% of portfolio
Black Rock Inc. New York, NY

3.62M
Shares

$23.4 Million
0.0% of portfolio
Kennedy Capital Management, Inc. St Louis, MO

1.47M
Shares

$9.5 Million
0.17% of portfolio

View Full List

About Aldeyra Therapeutics, Inc.

Ticker ALDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,323,100
Market Cap $377M
Description
Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...

More about ALDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account